Trials / Unknown
UnknownNCT03783832
Follow up of Diabetic Macular Edema Treated by Aflibercept (Eylea®) With OCT-Angiography
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 48 (estimated)
- Sponsor
- Aquitania Opthalmologica · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a non-interventional, longitudinal, retrospective and prospective, non-controlled, single arm study in naive or non-naive patients with diabetic macular edema for which aflibercept (EYLEA®) therapy is indicated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | OCT ANGIOGRAPHY DATA | Follow-up of diabetic macular edema treated by Aflibercept (EYLEA®) with OCT angiography |
Timeline
- Start date
- 2018-06-19
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2018-12-21
- Last updated
- 2018-12-21
Locations
6 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03783832. Inclusion in this directory is not an endorsement.